Binding sites of anticancer drugs on human serum albumin (HSA): a review
P Molaei, H Mahaki, H Manoochehri… - Protein and peptide …, 2022 - ingentaconnect.com
Background: To recognize the action of pharmacologically approved anticancer drugs in
biological systems, information regarding its pharmacokinetics, such as its transport within …
biological systems, information regarding its pharmacokinetics, such as its transport within …
[HTML][HTML] Investigating the role of peptides in effective therapies against cancer
R Naeimi, A Bahmani, S Afshar - Cancer Cell International, 2022 - Springer
Early diagnosis and effective treatment of cancer are challenging. To diagnose and treat
cancer effectively and to overcome these challenges, fundamental innovations in traditional …
cancer effectively and to overcome these challenges, fundamental innovations in traditional …
[HTML][HTML] CircRNA hsa_circ_0002577 accelerates endometrial cancer progression through activating IGF1R/PI3K/Akt pathway
Y Wang, L Yin, X Sun - Journal of Experimental & Clinical Cancer …, 2020 - Springer
Background Endometrial cancer (EC) is a common gynecologic malignancy worldwide. This
study investigated the regulatory effects of circular RNA (circRNA) hsa_circ_0002577 on the …
study investigated the regulatory effects of circular RNA (circRNA) hsa_circ_0002577 on the …
Identification of key genes in colorectal cancer diagnosis by weighted gene co-expression network analysis
Background The purpose of this study was using bioinformatics tools to identify biomarkers
and molecular factors involved in the diagnosis of colorectal cancer, which are effective for …
and molecular factors involved in the diagnosis of colorectal cancer, which are effective for …
[HTML][HTML] A systems biology approach to identify novel biomarkers in progression from Crohn's disease to colorectal cancer
N Shokrollah, P Samadi, A Jalali… - Asian Pacific Journal …, 2023 - ncbi.nlm.nih.gov
Objective: This study aimed to find the key genes and miRNAs as potential biomarkers
related to the progression of colorectal cancer (CRC) from Crohn's disease (CD) …
related to the progression of colorectal cancer (CRC) from Crohn's disease (CD) …
[HTML][HTML] A network-based pharmacological investigation to identify the mechanistic regulatory pathway of andrographolide against colorectal cancer
B Janani, M Vijayakumar, K Priya, JH Kim… - Frontiers in …, 2022 - frontiersin.org
Traditional cancer treatments have posed numerous obstacles, including toxicity, multiple
drug resistance, and financial cost. On the contrary, bioactive phytochemicals used in …
drug resistance, and financial cost. On the contrary, bioactive phytochemicals used in …
Design and synthesis of novel pyrazolopyrimidine candidates as promising EGFR-T790M inhibitors and apoptosis inducers
Aim: Our objective was to design and synthesize a new range of pyrazolopyrimidines while
maintaining the key pharmacophoric features of EGFR tyrosine kinase inhibitors. Materials & …
maintaining the key pharmacophoric features of EGFR tyrosine kinase inhibitors. Materials & …
Investigating the effect of radiosensitizer for Ursolic Acid and Kamolonol Acetate on HCT-116 cell line
Purpose The aim of this study was evaluating the cytotoxic and radiosensitizing effects of
Ursolic Acid (UA) and Kamolonol Acetate (KA) on HCT116 cell line and finally investigating …
Ursolic Acid (UA) and Kamolonol Acetate (KA) on HCT116 cell line and finally investigating …
[HTML][HTML] Introducing novel key genes and transcription factors associated with rectal cancer response to chemoradiation through co-expression network analysis
Preoperative radiochemotherapy is a promising therapeutic method for locally advanced
rectal cancer patients. However, the response of colorectal cancer (CRC) patients to …
rectal cancer patients. However, the response of colorectal cancer (CRC) patients to …
N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells
J Lai, Z Zhou, K Hu, HL Yu, X Su, X Niu, H Li, S Mao - Epigenetics, 2024 - Taylor & Francis
ABSTRACT N6 methyladenosine (m6A), methylation at the sixth N atom of adenosine, is the
most common and abundant modification in mammalian mRNAs and non-coding RNAs …
most common and abundant modification in mammalian mRNAs and non-coding RNAs …